AstraZeneca's targeted therapy shows benefits for those with advanced breast cancer, trial shows

Results showed the therapy demonstrated a 40% reduction in the risk of disease progression or death versus its placebo.

Related Keywords

San Antonio ,Texas ,United States ,California ,South San Francisco ,American ,Sylvia Adams ,Nicholas Turner ,Susan Galbraith ,Astrazeneca ,Langone Health ,Cancer Center ,Drug Administration ,American Cancer Society ,Antonio Breast Cancer ,Getty Images ,American Cancer ,Health ,News ,Cancer ,